Abstract
Smell dysfunction has been recognized as an early symptom of SARS-CoV-2 infection, often occurring before the onset of core symptoms of the respiratory tract, fever or muscle pain. In most cases, olfactory dysfunction is accompanied by reduced sense of taste, is partial (microsmia) and seems to normalize after several weeks, however, especially in cases of virus-induced complete smell loss (anosmia), there are indications of persisting deficits even 2 months after recovery from the acute disease, pointing towards the possibility of chronic or even permanent smell reduction for a significant part of the patient population. To date, we have no knowledge on the specificity of anosmia towards specific odorants or chemicals and about the longer-term timeline of its persistence or reversal.
| Originalsprache | Englisch |
|---|---|
| Fachzeitschrift | American Journal of Otolaryngology |
| Volume | 42 |
| Issue | 5 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 2021 |
Research Field
- Biosensor Technologies
Fingerprint
Untersuchen Sie die Forschungsthemen von „Olfactory dysfunction in SARS-CoV-2 infection: Focus on odorant specificity and chronic persistence“. Zusammen bilden sie einen einzigartigen Fingerprint.Diese Publikation zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver